To further verify the in vivo contribution of the POU6F2-AS1/FASN axis to promoting CRC cell growth and lipogenesis, we performed HCT116 cell growth assays and mouse tumour xenograft model experiments. This evidence concerns the gene FASN and colorectal carcinoma.